Involvement of long non-coding RNA NORAD in short-term poor prognosis of neoadjuvant chemotherapy in adenocarcinoma of esophagogastric junction
High pretreatment NORAD expression is an independent risk factor for poor response to neoadjuvant chemotherapy. Downregulating NORAD restores oxaliplatin sensitivity in resistant cells.
Authors
- Shoumiao Li (ORCID: https://orcid.org/0000-0002-9814-519X)
- Zhiyong Nie
- Jing Wang
- Jiaxin Liu (ORCID: https://orcid.org/0000-0003-3508-9132)
- Hui Li (ORCID: https://orcid.org/0000-0002-7184-592X)
Institutions
- Henan Cancer Hospital (CN)
- Anyang Tumor Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-30
- DOI
- https://doi.org/10.1080/07853890.2025.2526109
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00